The Pacific Pediatric Neuro-Oncology Consortium, the Children’s Brain Tumor Tissue Consortium, and Seven Bridges recently released CAVATICA, a data analysis platform designed to facilitate the rapid integration of data from multiple diseases affecting children, including cancer and other rare diseases like congenital disorders, epilepsy, and autism.
The Pacific Pediatric Neuro-Oncology Consortium (PNOC) is a network of 15 children’s hospitals that conduct clinical trials of new therapies for children with brain tumors. Our goal is to improve outcomes by translating the latest findings in cancer biology into better treatments for these children.
Patients with brain tumors that cannot be treated with standard therapy, or that have recurred following standard therapy, are often eligible for clinical trials. Clinical trials provide access to promising new treatments that may not be available outside specialized centers.
At PNOC, our focus is personalized medicine – testing new therapies that are specific to the biology of each patient’s tumor to maximize their effectiveness. Our goal is to improve overall outcome for children with brain tumors.